Reviewed by Michael Gill, B. Sc.
12 Retinoblastoma Clinical Trials Near Me
Top Hospitals for Retinoblastoma Clinical Trials
Image of St. Jude Children's Research Hospital in Tennessee.
St. Jude Children's Research Hospital
Memphis
3Active Trials
10All Time Trials for Retinoblastoma
1997First Retinoblastoma Trial
Image of Cleveland Clinic Foundation in Ohio.
Cleveland Clinic Foundation
Cleveland
2Active Trials
6All Time Trials for Retinoblastoma
2005First Retinoblastoma Trial
Top Cities for Retinoblastoma Clinical Trials
Image of San Francisco in California.
San Francisco
4Active Trials
UCSF Medical Center-ParnassusTop Active Site
Image of Houston in Texas.
Houston
4Active Trials
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer CenterTop Active Site
Retinoblastoma Clinical Trials by Phase of Trial
Phase 1 Retinoblastoma Clinical Trials
5Active Retinoblastoma Clinical Trials
5Number of Unique Treatments
6Number of Active Locations
Most Recent Retinoblastoma Clinical Trials
Top Treatments for Retinoblastoma Clinical Trials
Treatment Name
Active Retinoblastoma Clinical Trials
All Time Trials for Retinoblastoma
First Recorded Retinoblastoma Trial
Melphalan
2
10
2009
Treatment (CVE, melphalan)
1
1
2022
second generation 4-1BBζ B7H3-EGFRt-DHFR
1
1
2020
Topotecan Episcleral Plaque
1
1
2020
Episcleral Topotecan
1
1
2021

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 12th, 2021

Last Reviewed: October 22nd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Hattinger CM, Patrizio MP, Magagnoli F, Luppi S, Serra M. An update on emerging drugs in osteosarcoma: towards tailored therapies? Expert Opin Emerg Drugs. 2019 Sep;24(3):153-171. doi: 10.1080/14728214.2019.1654455. Epub 2019 Aug 14. Review. https://pubmed.ncbi.nlm.nih.gov/314019032 Dunkel IJ, Piao J, Chantada GL, Banerjee A, Abouelnaga S, Buchsbaum JC, Merchant TE, Granger MM, Jubran RF, Weinstein JL, Saguilig L, Abramson DH, Krailo MD, Rodriguez-Galindo C, Chintagumpala MM. Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321). J Clin Oncol. 2022 Jul 12:JCO2102337. doi: 10.1200/JCO.21.02337. [Epub ahead of print] https://pubmed.ncbi.nlm.nih.gov/35820112